ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,768, issued on Feb. 18, was assigned to Factor Bioscience Inc. (Cambridge, Mass.).
"Methods and products for transfection" was invented by Matthew Angel (Cambridge, Mass.) and Christopher Rohde (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed."
The patent was filed on Oct. 3, 2022, under Application No. 17/958,816.
*For further informat...